-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Achilles Therapeutics plc quarterly/annual Depreciation history and growth rate from Q2 2022 to Q2 2024.
- Achilles Therapeutics plc Depreciation for the quarter ending June 30, 2024 was $1.2M, a 7.69% decline year-over-year.
- Achilles Therapeutics plc annual Depreciation for 2023 was $4.7M, a 27% increase from 2022.
- Achilles Therapeutics plc annual Depreciation for 2022 was $3.7M, a 12.1% increase from 2021.
- Achilles Therapeutics plc annual Depreciation for 2021 was $3.3M, a 313% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)